Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
77.92
-6.82 (-8.05%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Sol-Gel Technologies Employees
Sol-Gel Technologies had 28 employees as of December 31, 2025. The number of employees decreased by 6 or -17.65% compared to the previous year.
Employees
28
Change (1Y)
-6
Growth (1Y)
-17.65%
Revenue / Employee
$659,464
Profits / Employee
-$37,357
Market Cap
254.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | -6 | -17.65% |
| Dec 31, 2024 | 34 | -2 | -5.56% |
| Dec 31, 2023 | 36 | -19 | -34.55% |
| Dec 31, 2022 | 55 | 2 | 3.77% |
| Dec 31, 2021 | 53 | -12 | -18.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Bicycle Therapeutics | 288 |
| Zentalis Pharmaceuticals | 106 |
| Neumora Therapeutics | 92 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 55 |
| Surrozen | 44 |
| ALX Oncology Holdings | 43 |
SLGL News
- 7 weeks ago - Sol-Gel Technologies initiated with an Outperform at Mizuho - TheFly
- 2 months ago - Sol-Gel Technologies initiated with a Buy at TD Cowen - TheFly
- 2 months ago - Sol-Gel Technologies reports Q1 EPS ($1.31) vs. ($3.20) last year - TheFly
- 2 months ago - Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 2 months ago - Sol-Gel Technologies Earnings release: Q1 2026 - Filings
- 5 months ago - Sol-Gel Technologies 459K share Spot Secondary priced at $72.00 - TheFly
- 5 months ago - Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - GlobeNewsWire
- 5 months ago - Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 - GlobeNewsWire